Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
Biocon sells insulin and other brands to Eris for $150M
Biocon and Eris have expanded a previous agreement, with Biocon selling Indian branded formulations businesses to Mumbai-based Eris for $150M.
Kevin Dunleavy
Mar 14, 2024 11:34am
Charles River to help Navega produce gene therapy candidate
Mar 14, 2024 9:50am
BIO pledges support to bill targeting Chinese biotechs
Mar 13, 2024 6:09pm
After a pause, Aurobindo resumes drug shipments from India plant
Mar 13, 2024 3:40pm
Takeda to lay off 190 Austrian workers after gene therapy pivot
Mar 13, 2024 10:15am
Par recalls batch of Remodulin generic over particulate concerns
Mar 13, 2024 8:15am